HEALTH

Diamyd Medical to divide business

BY Alaric DeArment

STOCKHOLM Diamyd Medical will split its business into separate divisions for pain relief and diabetes, the drug maker said Friday.

 

The Swedish company said its diabetes business would consist mostly of the investigational antigen-based drug Diamyd, for Type 1 diabetes, while the pain business would comprise of development projects using its nerve-targeting drug delivery system platform to administer drugs directly to the nervous system to treat pain.

 

 

The company will begin the division process during the new 2010-2011 fiscal year.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Transcript Pharmacy receives ACHC accreditation

BY Allison Cerra

JACKSON, Miss. A pharmacy that specializes in serving patients with chronic medical conditions has received accreditation status from the Accreditation Commission for Health Care for specialty pharmacy services.

Transcript Pharmacy said Wednesday it was awarded ACHC accreditation, a voluntary activity where healthcare organizations submit to peer review of their internal policies, processes and patient care delivery against national standards. Transcript recently was involved in a year-long study conducted by Virginia Commonwealth University, which showed that through personalized communication with each patient, Transcript improved compliance.

“This recognition demonstrates that the level of care and quality of services we offer bring significant benefits to the patients that we serve,” said company president Cliff Osbon.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

K-V establishes generic drug subsidiary Nesher Pharmaceuticals

BY Alaric DeArment

ST. LOUIS K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday.

 

K-V announced the establishment of Nesher Pharmaceuticals, appointing as its president Mark Hartman, who has had several positions in generic drug companies.

 

 

“Mark brings recognized depth and breadth of generic industry experience and leadership to K-V,” K-V interim president and CEO Greg Divis said. “We are excited to have Mark join our organization and look forward to him leading the introduction of Nesher Pharmaceuticals Inc., K-V’s new generic subsidiary.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?